News & Insights
Find all the latest research, news, and CEOi workgroup resources on digital cognitive assessments, blood-based biomarkers, and more breakthroughs in diagnostic tools and assessments for Alzheimer’s disease.
Featured
Stories
FDA Grants Breakthrough Device Designation to pTau 217 Blood Test for Alzheimer Disease
Go To Resource
News and Insight Library for Alzheimer’s Diagnostic Tools and Assessments
Primary Care Detection of Alzheimer’s Disease Using a Self-Administered Digital Cognitive Test and Blood Biomarkers
Go To Resource
Digital Cognitive Assessments: Coding and Reimbursement Resource for Healthcare Professionals
Go To Resource
The Global CEO Initiative on Alzheimer’s Disease Launches Groundbreaking Alzheimer’s Blood Test Performance Database for Clinicians
Go To Resource
CEOi Launches Three Part Podcast Series, “A Breakthrough in Alzheimer’s Diagnostics: Integrating Blood Tests into Clinical Practice” in partnership with Pri-Med
Go To Resource
FDA Grants Breakthrough Device Designation to pTau 217 Blood Test for Alzheimer Disease
Go To Resource
Cutting through the noise: A narrative review of Alzheimer’s disease plasma biomarkers for routine clinical use
Read More
Go To Resource
NeuroVoices: Rebecca M. Edelmayer, PhD, on Advancing Blood Biomarkers in Alzheimer Disease for Earlier Diagnosis and Treatment Intervention
Go To Resource
VJNeurology Webinar: Translating Novel Diagnostics into Practice: Updates for Neurodegenerative Diseases.
Go To Resource
Blood-based biomarkers for Alzheimer’s present complex challenges to health care system
Go To Resource